Home › Funds › Ally Bridge Group (NY) LLC › ALMS
Ally Bridge Group (NY) LLC position in ALMS
ALUMIS INC · Health Care
Ally Bridge Group (NY) LLC reported holding 400,000 shares of ALMS (ALUMIS INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 3.93% of its reported portfolio and ranking #9 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed ALMS holdings in 6 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's ALMS position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in ALMS in Q2 2024 at 618,750 shares (US$8.2M). Across 6 filings, Ally Bridge Group (NY) LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 400,000 shares valued at US$3.0M — an increase of 323,541 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2024 (shares fell 26% over the following quarter), a 54% trim in Q2 2026 (shares fell 74% over the following quarter), a 423% increase in Q3 2026 (shares fell 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 618.75K | $8.23M | New |
| Q3 2024 | 418.42K | $4.47M | Reduce |
| Q4 2024 | 445.26K | $3.50M | Add |
| Q1 2026 | 166.96K | $3.68M | New |
| Q2 2026 | 76.46K | $2.15M | Reduce |
| Q3 2026 | 400.00K | $2.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALMS and 13F data
ALMS (ALUMIS INC) is a Health Care company. 49 other funds we track also report a position in ALMS — the largest reported positions include AyurMaya Capital Management Company, LP (US$111.9M), Deep Track Capital, LP (US$55.2M), Samsara BioCapital, LLC (US$53.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALMS
- AyurMaya Capital Management Company, LP 15.14M sh · $111.88M · Q3 2026
- Deep Track Capital, LP 7.47M sh · $55.20M · Q3 2026
- Samsara BioCapital, LLC 7.24M sh · $53.47M · Q3 2026
- Foresite Capital Management V, LLC 5.90M sh · $43.58M · Q3 2026
- Nextech Invest Ltd. 4.55M sh · $33.63M · Q3 2026
- Foresite Capital Management VI LLC 4.25M sh · $31.39M · Q3 2026
- venBio Partners LLC 4.19M sh · $30.97M · Q3 2026
- Saturn V Capital Management LP 2.86M sh · $21.10M · Q3 2026
- Opaleye Management Inc. 550.00K sh · $15.48M · Q2 2026
- Cormorant Asset Management, LP 2.08M sh · $15.33M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.96M sh · $14.48M · Q3 2026
- Novo Holdings A/S 1.25M sh · $9.24M · Q3 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held ALMS?
Ally Bridge Group (NY) LLC has disclosed ALMS holdings in 6 of the last 10 reported quarters, going back to Q2 2024.
What is Ally Bridge Group (NY) LLC's current position in ALMS?
As of Q3 2026, Ally Bridge Group (NY) LLC holds 400.00K shares of ALMS (ALUMIS INC), valued at $2.96M, representing 3.93% of its reported portfolio and ranking #9.
Has Ally Bridge Group (NY) LLC been buying or selling ALMS?
In the latest 13F filing (Q3 2026), Ally Bridge Group (NY) LLC increased its position in ALMS.
Which other funds hold ALMS?
Other major institutional holders of ALMS include AyurMaya Capital Management Company, LP, Deep Track Capital, LP, Samsara BioCapital, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.